Speakers

Alexandra Stärk

Alexandra Stärk

Novartis Pharma Stein

Theresa Ladwig

Theresa Ladwig

SKAN

Katharina Schlereth

Katharina Schlereth

Labor LS

Yves Scholler

Yves Scholler

SKAN

Ruben Rizzo

Ruben Rizzo

SKAN

Jordi Ruano

Jordi Ruano

Hipra

Dr Tarik Cheema

Dr Tarik Cheema

F. Hoffmann-La Roche

Participate in all four workshops at SKAN AG
 
The number of participants is limited.

Please understand that, for competitive reasons, not all companies can register their employees for this event.


Target Group

This GMP Education Course addresses those employees from the pharmaceutical industry and from suppliers for aseptic (toxic) manufacture and for sterility testing involved in the engineering, validation and operation of these systems, especially from the areas
  • Engineering / Production
  • Quality Assurance
  • Qualification/ Validation
  • Microbiology

Objectives

Why should you attend this event?
  • You get an update on isolators for aseptic manufacture and for sterility testing
  • You get to know the results of recent studies on the validation of Isolators
  • You have the opportunity to discuss your individual questions personally with experts
  • You can translate the theory directly into practice during 4 workshops at the manufacturing site of Skan in Allschwil
Each participant takes part in all 4 workshops. The workshops are held at the plant of SKAN AG, partly including operational isolators. This brings the participants as close to daily practice as possible.
 
The use of isolators is increasing both in sterility testing and in the production of sterile medicinal products, particularly in aseptic manufacture. It ensures a greater microbiological safety of the products, but at the same time requires increased inputs as regards the qualification of these systems and the validation of the production processes. In 2004, Appendix 1 to the FDA Guidance for Industry "Sterile Drug Products Produced by Aseptic Processing" defined new regulatory requirements on using this technology, as did the PIC/S document PI 014-3 "Isolators used for Aseptic Processing and Sterility Testing“. The current EU GMP Annex 1 from 2022 also deals with isolators in great detail.


Programme

Regulatory Requirements for Isolators for Aseptic Use
  • Regulatory bodies
  • US laws and regulations
  • European laws and regulations
  • Guidelines
Isolator Application / Projects: From the Conceptual Design to the Validated Equipment incl. Mock-Up Study
  • Key decisions
  • What do we need from our customers?
  • From URS to engineering – technical details and solutions
  • Process challenges and features
  • FAT – Installation – Qualification
  • Purpose of mock-up
  • What is required before starting a mock-up
  • How to document a mock-up
  • What simulations need to be included in the mock-up
  • Execution of the mock-up itself
  • Examples for our mock-up to underline the points above
From Concept to Inspection: Implementation and Validation of HIPRA’s Aseptic Filling Isolator Line under EU GMP Annex
  • End-to-end implementation of HIPRA’s first aseptic filling isolator line aligned with EU GMP Annex 1 and successfully inspected and approved. Project, installation, mock-up, smoke studies and VHP process studies.
  • Robust VHP decontamination and aseptic process Validation
  • Risk-based contamination control strategy integrating glove integrity testing before and after each batch/campaign, mock-up studies, airflow validation, and worst-case media fills.
  • Strong operational performance: environmental control results
Isolators Used for Sterility Testing
  • Requirements for the isolator
    • Background of the isolator
    • Performance Qualification
    • Qualification of operators
    • Test for gas-tightness of primary packaging materials
  • Handling in isolator
    • Capacity
    • Testing the tightness of gloves
  • Microbiological Monitoring
    • Sample plan
    • Contamination level
    • Contamination source
    • OOS/CAPA (example)
Bioindicators / Process Development of Isolator Decontamination
  • Overview of current regulations and standards
  • Basis and selection of suitable biological indicators as sensor for the inactivation effect
  • Development and quantification of decontamination cycles
  • Influence of H2O2 to routine processes
Initial Validation by Media Fill of a Syringe Isolator Filling Line
  • General Media Fill Design
  • Line-specific Media Fill Design
  • Media Fill Failure with Root Cause
  • Inspection Feedback to Media Fill Design
Troubleshooting in Isolator Technology
  • Annex 1 – What changed and why
  • The role of isolators
  • Key Annex 1 Challenges in Aseptic Isolator Manufacturing
  • Navigating the Challenges
  • Key Takeaways
     
Workshop Session
Workshop 1: Validation Planning for an Aseptic Isolator
  • Test master plan (IQ/OQ)
  • IQ / OQ test protocols
  • Operational qualification - procedures
  • Handling of deviations
Performance of Selected Qualification Tests
  • Basic SOP for testing
  • Execution of tests
  • Generate test records
  • Drawing up the test report
  • Glove testing
Glove integrity testing
  • Regulatory Background
  • Physical methods for glove integrity tests and their boundaries
  • Microbiological contamination risk
  • Routine program for glove integrity testing
Workshop 2: Development and Quantification of H2O2 Decontamination Cycles
  • Establish the requirements of a decontamination cycle
  • Design a qualification strategy
  • Work out the necessary physical and microbiological tests and their chronology
  • Interpretation of test results and reaction on deviations
  • Write a transparent qualification report
  • Workshop including a real isolator system
Workshop 3: Isolators VR Mockup
  • Isolator Design engineering using Virtual Reality (VR)
  • Use of real-world objects for physical feedback and position validation (XR experience)
  • Ergonomic assessment and future manipulation simulation
Workshop 4: Plant tour incl. E-Beam
  • Design of an isolator
  • Construction details


Further Information

Venue
Pullman Basel Europe
Clarastr. 43
4058 Basel
Switzerland
 +41 61 690 80-80
h5921@accor.com
 
Accommodation
CONCEPT HEIDELBERG has reserved a limited number of rooms. You will receive a room reservation form/POG when you have registered for the course. Reservation should be made directly with the hotel. Early reservation is recommended.

Fees (per delegate, plus VAT)
ECA Members EUR 1,990
APIC Members EUR 2,090
Non-ECA Members EUR 2,190
EU GMP Inspectorates EUR 1,095

The conference fee is payable in advance after receipt of invoice and includes dinner on the first day, lunch on both days and all refreshments. VAT is reclaimable.
 
Social Event
On 10 November 2026 you are cordially invited to a social event. This is an excellent opportunity to share your experiences with colleagues from other companies and the speakers in a relaxed atmosphere.

Workshops on 11 November 2026 at SKAN AG
The four workshops will take place at SKAN AG in Allschwil. After the workshops, at appr. 16:05 h, a bus shuttle service will bring the participants to the airport (appr. 16:25 h), the Swiss train station (appr. 16:55 h), the German train station (appr. 17:10 h), or to the hotel.
 
Presentations/Certificate
The presentations for this event will be available for you to download and print before and after the event. Please note that no printed materials will be handed out on site and that there will not be any opportunity to print the presentations on site. After the event, you will automatically receive your certificate of participation.
 
Conference language
The official conference language will be English.
 
Contacts
Questions regarding content:
Dr Andreas Mangel, +49 6221 84 44-40, mangel@concept-heidelberg.de
Questions regarding organisation:
Mr Rouwen Schopka +49 6221 84 44-22, schopka@concept-heidelberg.de

 


Date & Time

Tue, 10 Nov 2026
(Registration and coffee 08:30-09:00 h)
09:00-18:00 h
Wed, 11 Nov 2026, 08:00-16:05 h

After the workshops on 11 November 2026 at appr. 16:05 h, a bus shuttle service will bring the participants to the airport, the train stations or the hotel.

All times mentioned are CET.

Costs

ECA-Member*: € 1990,-
Non ECA Member*: € 2190,-
EU/GMP Inspectorates*: € 1095,-
APIC Member Discount*: € 2090,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Recording/ Additional dates on-site
not available
Recording/ Additional dates on-site
not available
stop

This course is part of the GMP Certification Programme "ECA Certified Sterile Production Manager"

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

“I found the course eye opening and very well organized.”

Jozsef Maklary, Veolia Industries Austria GmbH
The GMP-Compliance Manager, October 2025

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025